 EID Parry IndiaOther Food Products | Q1 FY27 Results: Standalone Loss Widens to Rs 89 Crore12 Aug 2026Pat NegativeRevenue DeclineEbitda Margin Compression | -0.1% +1.8% -10.4% | ₹684 | 12,167 Cr | 26.2vs 25.7 | 13.1% | +3.4% |
 JK Tyre & IndustriesTyres & Rubber Products | JK Tyre Q1 FY27 results: Revenue down 6.6%, PAT plunges 76% YoY7 Aug 2026Revenue DeclinePat NegativeEbitda Margin Compression | -6.8% -7.4% -10.8% | ₹333 | 9,586 Cr | 14.3vs 25.4 | 9.9% | +2.0% |
 Signatureglobal IndiaResidential Commercial Projects | Signatureglobal Q1FY27: Revenue drops 37% YoY, swings to loss6 Aug 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | +2.0% -0.4% -1.4% | ₹708 | 9,961 Cr | 9.5vs 20.8 | 34.7% | -36.2% |
 Cohance LifesciencesPharmaceuticals | Q1FY27: Revenue falls 23%, PAT turns negative on weak CDMO and NJ Bio losses5 Aug 2026Revenue DeclinePat NegativeEbitda Margin Compression | +4.2% +4.3% +5.5% | ₹442 | 16,911 Cr | 108.9vs 31.2 | 4.1% | -23.1% |
 Nazara TechnologiesDigital Entertainment | Nazara Q1 FY27: Rs 82 Cr loss, revenue dips 14%, new CEO from Sept3 Aug 2026Revenue DeclinePat NegativeEbitda Margin Compression | +2.4% +5.0% +8.9% | ₹377 | 13,960 Cr | — | 8.6% | -14.0% |
 Indo Count IndustriesOther Textile Products | Indo Count Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.30 May 2026Pat NegativeEbitda Margin CompressionRevenue Decline | +9.8% +3.4% +38.4% | ₹448 | 8,863 Cr | 58.7vs 16.4 | 5.4% | +25.9% |
 Jupiter WagonsRailway Wagons | Jupiter Wagons Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.30 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -1.6% -6.8% -7.9% | ₹216 | 9,248 Cr | 57.5 | 7.6% | +46.0% |
 JAI Balaji IndustriesJAIBALAJI | Consideration and approval of the Audited Financial Results of the Company for the fourth quarter and year ended 31st March, 2026, amongst other items of agenda.30 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -3.2% -9.6% -5.3% | ₹68.05 | 6,208 Cr | 21.2 | 5.7% | -13.1% |
 Swan CorpPetrochemicals | Outcome of Board Meeting held on 29th May, 2026.29 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -3.9% -5.4% -4.4% | ₹261 | 8,181 Cr | 39.3vs 14.5 | 3.3% | -16.4% |
 Concord BiotechPharmaceuticals | Outcome of Board Meeting held today i.e. Friday, May 29, 2026 wherein the Board inter-alia considered and approved Audited Financial results and statements for the Financial Year ended ....29 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +12.3% +25.6% +22.5% | ₹1,358 | 14,207 Cr | 52.0vs 31.2 | 16.5% | +26.2% |
 Natco PharmaPharmaceuticals | Audited Financial Results for the quarter and year ended 31st March, 202629 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -20.7% -26.4% -22.1% | ₹795 | 14,227 Cr | 12.4vs 31.2 | 15.9% | -44.7% |
 Tega IndustriesIndustrial Products | Tega Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.29 May 2026Pat NegativeEbitda Margin CompressionRevenue Decline | +12.7% +12.2% +5.9% | ₹1,958 | 14,712 Cr | 516.7vs 28.5 | 5.4% | +384.0% |
 Praj IndustriesIndustrial Products | Press Release regarding Audited Financial Results.28 May 2026Pat NegativeEbitda Margin CompressionRevenue Decline×2 | -12.4% -7.3% -9.9% | ₹291 | 5,340 Cr | 177.1vs 28.5 | 3.5% | +11.8% |
 Deepak Fertilizers & PetrCommodity Chemicals | Statement of Audited Standalone and Consolidated Financial results for the quarter and year ended 31st March, 202628 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression×2 | -3.5% +4.9% +6.6% | ₹1,391 | 17,560 Cr | 17.8vs 18.9 | 8.4% | +22.5% |
 Morepen Lab.Pharmaceuticals | Morepen Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -2.5% -3.6% +23.8% | ₹139 | 7,605 Cr | 54.2vs 31.2 | 8.3% | +34.1% |
 GMR Pow and Urban InfraPower Generation | Approval of Audited financial results (Standalone & Consolidated) for the quarter and year ended March 31, 202621 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -7.1% -6.0% -12.5% | ₹97.33 | 7,602 Cr | 12.1vs 20.4 | 5.2% | +3.4% |
 EmamiPersonal Care | Emami Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.21 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -5.7% -8.3% -4.8% | ₹367 | 16,020 Cr | 21.4vs 35.6 | 28.4% | +14.9% |
 Whirlpool of IndiaHousehold Appliances | Whirlpool of India Limited has informed the Exchange about change in Management20 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression×2 | -1.7% -4.2% -5.0% | ₹823 | 10,442 Cr | 41.6vs 41.6 | 8.1% | +12.1% |
 ZEE Entertainment ENTTV Broadcasting & Software Production | Board of Directors at its meeting held on May 19, 2026 recommended final dividend19 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -4.6% +7.1% +31.6% | ₹68.48 | 6,610 Cr | 18.9vs 18.9 | 2.3% | +4.5% |
 Afcons InfrastructureCivil Construction | Please find enclosed the intimation of press release on the Audited Financial Result of the Company for the quarter and financial Year Ended March 31, 202618 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×4 | -4.6% +6.2% -1.7% | ₹242 | 8,918 Cr | 62.2vs 14.6 | 4.2% | -20.8% |
 Clean Science & TechSpecialty Chemicals | Board approved a) Audited Standalone & Consolidated Financial Results for FY26. b) Recommended final dividend of Rs.4/- (400%) per Share c) Additional investment of Rs. 200 Crores in one ....14 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -6.8% -9.4% -3.7% | ₹795 | 8,451 Cr | 36.3vs 24.3 | 19.1% | +10.5% |
 Akums Drugs and PharmaPharmaceuticals | Appointment of Internal Auditors for the FY 2026-2714 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -4.3% -3.5% +14.6% | ₹785 | 12,017 Cr | 41.2vs 31.2 | 8.8% | +13.9% |
 Onesource Specl PharmaPharmaceuticals | Onesource announces FY 2026 results with strong Q4 performance; reaffirms FY28 guidance.13 May 2026Revenue DeclineEbitda Margin CompressionPat Negative | -0.8% -0.3% -11.4% | ₹1,480 | 16,967 Cr | — | -1.4% | +37.2% |
 Vardhman TextilesOther Textile Products | Please find enclosed herewith Financial Results of the Company for the Quarter/ Financial Year ended 31.03.2026.7 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression | -4.2% -1.9% +1.7% | ₹527 | 15,244 Cr | 17.7vs 16.4 | 7.4% | +13.3% |
 PCBL ChemicalCarbon Black | PCBL Chemical Limited has informed the Exchange regarding 'Financial Results for the period ended 31-Mar-2026'.5 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | 0.0% -10.6% -9.5% | ₹320 | 12,592 Cr | 48.2 | 3.4% | +17.0% |
 Jaiprakash Power Ven.Power Generation | Audited Finacial Results for the quarter and financial year ended on 31st march 2026 together with modified auditors report and statement of impact.4 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression | +1.4% -6.4% +0.2% | ₹14.29 | 9,794 Cr | 20.4vs 20.4 | 4.6% | +12.2% |
 Tata ChemicalsCommodity Chemicals | Tata Chemicals Limited has informed the Exchange regarding a press release dated May 04, 2026, titled "Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026".4 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | +0.7% -6.8% -11.4% | ₹593 | 15,116 Cr | — | -5.0% | +14.4% |
 Jindal SawIron & Steel Products | Jindal Saw Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.27 Apr 2026Revenue DeclinePat NegativeEbitda Margin Compression | -6.5% -0.8% -1.3% | ₹270 | 17,267 Cr | 26.3vs 17.0 | 6.8% | +9.0% |
